US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Faeth Therapeutics

35.37

-3.7200-9.52%

Post-market: 35.880.5100+1.44%19:53 EDT

Volume:209.39K

Turnover:7.67M

Market Cap:911.80M

PE:-0.25

High:39.89

Open:38.75

Low:34.88

Close:39.09

52wk High:42.14

52wk Low:7.45

Shares:25.78M

Float Shares:811.70K

Volume Ratio:0.68

T/O Rate:25.80%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-141.6499

EPS(LYR):-16.7239

ROE:-195.26%

ROA:-20.79%

PB:5.27

PE(LYR):-2.11

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Faeth Therapeutics Director Karen H. Vousden Files Initial Beneficial Ownership Statement

Faeth Therapeutics initiated with a Buy at Guggenheim

Faeth Therapeutics Initiated at Buy by LUCID Capital Markets

Faeth Therapeutics assumed with a Buy at Lucid Capital

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/FTH"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":35.37,"timestamp":1789502400000,"preClose":39.09,"halted":0,"volume":209394,"hourTrading":{"tag":"盘后","latestPrice":35.88,"preClose":35.37,"latestTime":"19:53 EDT","volume":358,"amount":12833.5401,"timestamp":1789516430954,"change":0.51,"changeRate":0.014419,"amplitude":0.014419},"delay":0,"changeRate":-0.09516500383729869,"floatShares":811700,"shares":25778800,"eps":-141.6499,"marketStatus":"Not Yet Opened","change":-3.72,"latestTime":"09-15 16:00:00 EDT","open":38.75,"high":39.89,"low":34.88,"amount":7666233.875244,"amplitude":0.128166,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-141.6499,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":39.09,"postHourTrading":{"tag":"盘后","latestPrice":35.88,"preClose":35.37,"latestTime":"19:53 EDT","volume":358,"amount":12833.5401,"timestamp":1789516430954,"change":0.51,"changeRate":0.014419,"amplitude":0.014419},"volumeRatio":0.675028},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-20.79%","roe":"-195.26%","lyrEps":-16.72388,"volumeRatio":0.675028,"shares":25778800,"dividePrice":0,"high":39.89,"amplitude":0.128166,"preClose":39.09,"low":34.88,"week52Low":7.45,"pbRate":"5.27","week52High":42.1431,"institutionHeld":0,"latestPrice":35.37,"eps":-141.6499,"divideRate":0,"volume":209394,"delay":0,"ttmEps":-141.6499,"open":38.75,"prevYearClose":10.67,"prevWeekClose":37.44,"prevMonthClose":32.77,"prevQuarterClose":25,"fiveDayClose":39.2,"twentyDayClose":32.77,"sixtyDayClose":17.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"FTH","fiscalQuarterEnding":"2026/06","expectedEps":-1.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-2.84},{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5833,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1789012800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-09-14","current":-0.2497,"percent":0.101695,"low":-5.292894,"twenty":-4.561008,"median":-3.985108,"eighty":-3.360395,"high":-0.105707,"avg":-3.827199,"sd":1.140745,"marketCap":967465512},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-26","current":-3.447751,"twenty":-3.41449,"median":-0.168709,"eighty":-0.122832,"marketCap":635961861},{"date":"2026-07-02","current":-3.306599,"twenty":-3.429583,"median":-3.245107,"eighty":-0.129642,"marketCap":609925319},{"date":"2026-07-10","current":-4.547622,"twenty":-3.49387,"median":-3.330357,"eighty":-0.168709,"marketCap":838840655},{"date":"2026-07-17","current":-3.62524,"twenty":-4.398084,"median":-3.429583,"eighty":-3.196193,"marketCap":668700878},{"date":"2026-07-24","current":-3.879594,"twenty":-4.005373,"median":-3.554664,"eighty":-3.20318,"marketCap":715618211},{"date":"2026-07-31","current":-4.027734,"twenty":-4.074133,"median":-3.637119,"eighty":-3.236722,"marketCap":742943690},{"date":"2026-08-07","current":-3.227486,"twenty":-4.048697,"median":-3.62524,"eighty":-3.239088,"marketCap":631063897},{"date":"2026-08-14","current":-3.773087,"twenty":-4.030809,"median":-3.711043,"eighty":-3.239088,"marketCap":737744133},{"date":"2026-08-21","current":-4.242245,"twenty":-4.248589,"median":-3.806921,"eighty":-3.244483,"marketCap":829477642},{"date":"2026-08-28","current":-4.458983,"twenty":-4.358015,"median":-3.881185,"eighty":-3.294301,"marketCap":871855939},{"date":"2026-09-04","current":-5.154129,"twenty":-4.410264,"median":-3.939688,"eighty":-3.344613,"marketCap":1007776575},{"date":"2026-09-11","current":-5.154129,"twenty":-4.552871,"median":-3.964844,"eighty":-3.358825,"marketCap":1007776575},{"date":"2026-09-14","current":-4.947964,"twenty":-4.561008,"median":-3.985108,"eighty":-3.360395,"marketCap":967465512}],"updateTime":1789541912556},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTH\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667622649","title":"Faeth Therapeutics Director Karen H. Vousden Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667622649","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667622649?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:57","pubTimestamp":1789505864,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics director Karen H. Vousden files initial beneficial ownership statementFaeth Therapeutics director Karen H. Vousden reported 42,631 shares of common stock held directly as of Sept. 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nNDLHBX1g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667762423","title":"Faeth Therapeutics initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2667762423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667762423?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:20","pubTimestamp":1789503654,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Brad Canino initiated coverage of Faeth Therapeutics (FTH) with a Buy rating and $70 price target Published first on TheFly – th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667766027","title":"Faeth Therapeutics Initiated at Buy by LUCID Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2667766027","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667766027?lang=en_us&edition=fundamental","pubTime":"2026-09-15 01:36","pubTimestamp":1789407360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FTH/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667812662","title":"Faeth Therapeutics assumed with a Buy at Lucid Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667812662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667812662?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:55","pubTimestamp":1789397722,"startTime":"0","endTime":"0","summary":"Lucid Capital assumed coverage of Faeth Therapeutics (FTH) with a Buy rating and $59 price target The firm sees current share levels as offering an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-assumed-with-a-buy-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-assumed-with-a-buy-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCIZ","LCID","BK4596","FTH","LCDL","BK4555","BK4099","BK4139","BK4551"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":22,"pageCount":1,"totalSize":88,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FTH\",params:#limit:6,delay:false,,,undefined,":[]}}